Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (9) : clinical trials

Viatris Global Health Initiatives: Advancing NCD Care, Mental Health, and Digital Therapeutics

Viatris Global Health Initiatives: Advancing NCD Care, Mental Health, and Digital Therapeutics
10/17/2025 | Companies
Noncommunicable diseases (NCDs) are the world’s leading cause of death, creating an immense strain on individuals, healthcare systems, and economies. Every year, around 18 million people die prematurely—before reaching 70—from NCDs such as cardiovascular diseases, cancers, chronic respiratory...
accessible medicine, anxiety, Apixaban, art therapy, blood pressure management, BPV advocacy, cardiovascular disease, clinical trials, Cystadrops, depression, dermatology, diabetes, digital health, digital therapeutics, disease management, Dymista, Elidel, global collaboration, global health, global initiatives, government partnerships, HCP training, health apps, healthcare access, healthcare technology, hypertension, hypertension awareness, immersive VR therapy, innovative therapies, medication adherence, mental health, mental health awareness, multiple sclerosis, NCDs, noncommunicable diseases, ophthalmology, patient education, patient outcomes, patient support, pharmaceutical launches, pharmacovigilance, podcasts, PrGlatiramer Acetate, public health campaigns, Relpax, research, respiratory diseases, Rizmoic, RRMS, RYZUMVI, sotagliflozin, stigma reduction, stroke, Sugammadex, telemedicine, Viatris, Zeforus

Gilead’s Moupali Das Wins AAAS Breakthrough Award for HIV Prevention

Gilead’s Moupali Das Wins AAAS Breakthrough Award for HIV Prevention
06/20/2025 | Companies
Gilead has long been at the forefront of HIV research and innovation. We’re excited to announce that our own Moupali Das has received the prestigious AAAS Mani L. Bhaumik Breakthrough of the Year Award for her groundbreaking contributions to HIV prevention. This honor highlights her instrumental...
AAAS award, breakthrough of the year, clinical trials, Gilead, HIV prevention, HIV research, HIV trial program, Mani L. Bhaumik Award, medical innovation, Moupali Das, public health, scientific recognition

Teva’s Global Innovation Strategy: Advancing Healthcare Through Collaboration and Research

Teva’s Global Innovation Strategy: Advancing Healthcare Through Collaboration and Research
06/18/2025 | Companies
Advancing Access to Healthcare through Innovation and Partnerships Expanding access to medicines and healthcare relies on the continuous creation of evidence-driven solutions to address unmet medical needs. To support this mission, we actively engage in collaborative scientific efforts with...
academic partnerships, academic research, AI drug development, AI in healthcare, AION Labs, BioInnovators Forum, biologics, biomarkers, clinical trials, disease burden, drug discovery, epidemiology, healthcare access, healthcare innovation, IMI, innovation, Israeli biotech, medical education, neurodegenerative diseases, Organospheres, patient access, pharmaceutical research, pharmaceutical startups, public health research, public-private partnerships, PubMed publications, R&D, scientific collaboration, Teva Pharmaceuticals, translational medicine, unmet medical needs

Gilead & Kite Pharma Unveil Breakthrough Cancer Research at ASCO & EHA 2025

Gilead & Kite Pharma Unveil Breakthrough Cancer Research at ASCO & EHA 2025
05/29/2025 | Companies
GileadNews: In partnership with Kite Pharma, we are excited to share groundbreaking cancer research at this year’s American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) conferences. Our contribution includes over 20 abstracts, featuring late-breaking findings in...
American Society of Clinical Oncology, ASCO, cancer research, cancer treatment, CAR T-cell therapy, clinical trials, collaborative research, EHA, European Hematology Association, GileadNews, hematology, innovative therapies, investigational therapy, Kite Pharma, metastatic triple-negative breast cancer, oncology, Phase 2 results, recurrent glioblastoma, refractory multiple myeloma, relapsed multiple myeloma

Breakthrough HIV Treatment: Gilead's Innovative Drug Discovery Journey

Breakthrough HIV Treatment: Gilead's Innovative Drug Discovery Journey
04/03/2025 | Companies
In 2006, Tomas Cihlar was well aware that, despite initial successes with combination therapy, HIV continued to be a global challenge with limited treatment options. At the time, he had been researching virology at Gilead for 12 years, and the first once-daily, single-tablet regimen for HIV...
antiviral therapy, biopharmaceuticals, biotechnology, breakthrough medicine, clinical trials, drug discovery, drug resistance, Gilead, global health, healthcare innovation, HIV, HIV prevention, HIV research, HIV treatment, medical innovation, medical science, pharmaceutical development, Tomas Cihlar, viral capsid, virology

Open Source AI Revolutionizing Healthcare: Innovations and Economic Benefits

Open Source AI Revolutionizing Healthcare: Innovations and Economic Benefits
01/23/2025 | Companies
Key Insights: Open Source AI in Healthcare: Open source AI is revolutionizing healthcare by facilitating significant innovations in medical technology and research. Practical Applications: Using models like Llama, researchers have enhanced the precision of radiological diagnostics and improved...
AI accessibility, clinical trials, data security, economic growth, error reduction, GDP growth, Guardian AI, health outcomes, healthcare innovation, healthcare research, Hypercube, Llama AI, medical technology, Mendel, open source AI, patient cohorting, patient privacy, radiological diagnostics, trial matching, Zauron Labs

Enhancing Diversity in Clinical Trials: Why It Matters for Drug Development

Enhancing Diversity in Clinical Trials: Why It Matters for Drug Development
01/15/2025 | Companies
Clinical trials play a vital role in the development of healthcare products, and there is an increasing awareness of the need for more diversity in participant pools. With the recent introduction of draft guidelines by the US Food and Drug Administration (FDA) that make Diversity Action Plans...
clinical research, clinical trial barriers, clinical trial diversity, clinical trial inclusion, clinical trial participation, clinical trial statistics, clinical trials, cultural competency, diversity in clinical trials, drug development, ethnic diversity, FDA guidelines, health equity, healthcare access, healthcare disparities, healthcare diversity, medical research, patient-centered development, pharmaceutical industry, Teva, underrepresented groups

Brii Biosciences Acquires Full Rights to BRII-179 for HBV Cure Advancement

Brii Biosciences Acquires Full Rights to BRII-179 for HBV Cure Advancement
01/01/2025 | Companies
Brii Biosciences Limited, a biotechnology company focused on developing treatments for diseases with significant unmet needs, announced its acquisition of intellectual property (IP) and other assets related to BRII-179 from VBI Vaccines, Inc., its subsidiaries, and creditors K2 VBI Equity Trust,...
biotechnology, Brii Biosciences, BRII-179, clinical trials, combination therapies, drug development, elebsiran, ENRICH study, functional cure, HBV, healthcare innovation, Hepatitis B Virus, intellectual property acquisition, know-how, patents, PEG-IFNα, Phase 2b study, shareholder value, unmet medical needs, VBI Vaccines

More Blacks should join clinical trials: metastatic breast cancer survivor

More Blacks should join clinical trials: metastatic breast cancer survivor
10/31/2022 | Companies
Clinical trials are important since they can help improve the outcomes. It is important that more Blacks join clinical trials in the United States. Stephanie Walker, a North Carolina native, attended her first breast cancer conference in the spring of 2018 and had a revelation she refers to as her...
BECOME research survey, Black community, Black people, Black women, breast cancer, clinical trials, conference, disease, early stage, metastatic breast cancer, Metastatic Breast Cancer Alliance, Stephanie Walker


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com